aibioNSPR InspireMD, Inc.
InspireMD (NSPR) news
InspireMD, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NSPR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest InspireMD news
We have not published a story on InspireMD yet. When there is news, it will appear here.
InspireMD annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $15.0 million | $13.6 million |
| Net income (loss) | -$48.8 million | -$32.0 million |
| Cash from operations | -$35.1 million | -$21.9 million |
| Cash and equivalents | $8.9 million | $18.9 million |
| Short-term investments | $45.3 million | $15.7 million |
Questions about InspireMD
What is the ticker symbol of InspireMD?
InspireMD, Inc. trades under the ticker NSPR on NASDAQ.
Where is InspireMD listed?
InspireMD, Inc. is listed on NASDAQ.
Which country or territory is InspireMD listed under?
Our directory records InspireMD, Inc. under United States.
Does aibio.space cover InspireMD?
aibio.space lists InspireMD, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Is InspireMD profitable?
InspireMD, Inc. reported a net loss of $48.8 million for the fiscal year ended Dec 31, 2025, and used $35.1 million of cash in operations, per its annual report to the SEC.
How much does InspireMD spend on research and development?
$15.0 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does InspireMD have?
$30.4 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: InspireMD
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Reported a financing. SEC Form 8-K (Items 1.01,3.02,7.01,9.01). Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,9.01). Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.03,5.07,9.01). Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 8-K (Items 7.01,8.01,9.01). Source
Stock chart
Listing details
- Company
- InspireMD, Inc.
- Ticker
- NSPR
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction